Ingalfarma announces the recent publication of its Multicenter, Phase 2, Clinical Trial, for the Evaluation of the Efficacy and Safety of Dentoxol® in the prevention of oral mucositis in head and neck cancer patients in the international journal Supportive Care in Cancer. «It has been very gratifying and enriching to have achieved this milestone for… Seguir leyendo PUBLICATION OF ESDOM STUDY
Menú